More about

Buprenorphine

News
May 11, 2023
6 min read
Save

Tips for starting medication in patients with opioid use disorder

Tips for starting medication in patients with opioid use disorder

SAN DIEGO — “Now more than ever,” physicians need to manage opioid use disorder with pharmacological treatment in the primary care setting, according to a speaker at the ACP Internal Medicine Meeting.

News
April 26, 2023
1 min read
Save

Buprenorphine initiation plateaued before pandemic despite clinical, policy efforts

Buprenorphine initiation plateaued before pandemic despite clinical, policy efforts

From 2016 to 2022, initiation of buprenorphine for opioid use disorder increased, then plateaued prior to the COVID-19 pandemic, with a median monthly retention rate of about 20%, according to a research letter published in JAMA.

News
March 31, 2023
2 min read
Save

APA: DEA telehealth guidelines should facilitate access to controlled substances

APA: DEA telehealth guidelines should facilitate access to controlled substances

The American Psychiatric Association has recommended the Drug Enforcement Administration ensure access to buprenorphine and other controlled drugs through telehealth to combat the opioid epidemic and the national mental health crisis.

News
March 30, 2023
2 min read
Save

Buprenorphine initiation in ED safe, effective among patients with OUD who use fentanyl

Buprenorphine initiation in ED safe, effective among patients with OUD who use fentanyl

Initiating buprenorphine in the ED to patients with opioid use disorder was safe, with fewer than 1% of patients experiencing precipitated withdrawal despite a high prevalence of fentanyl use, a recent study found.

News
March 30, 2023
2 min read
Save

Incentive program increases buprenorphine treatment in ED patients with opioid addiction

Incentive program increases buprenorphine treatment in ED patients with opioid addiction

Patients who attended a Pennsylvania hospital ED implementing a financial incentive program to increase opioid use disorder treatment engagement were more likely to start buprenorphine compared with patients at other hospitals.

News
March 14, 2023
2 min read
Save

Disability linked to treatment rates for opioid use disorder

Disability linked to treatment rates for opioid use disorder

Among Medicaid beneficiaries with opioid use disorder, those with a disability were less likely to receive medication treatment and to adhere to treatment for 6 months, according to findings published in JAMA Network Open.

News
January 30, 2023
4 min read
Save

Buprenorphine prescribing flexibilities did not increase overdose deaths

Buprenorphine prescribing flexibilities did not increase overdose deaths

The proportion of buprenorphine-involved overdose deaths did not significantly increase after prescribing flexibilities were introduced in the beginning of the COVID-19 pandemic, according to recent findings published in JAMA Network Open.

News
January 24, 2023
2 min read
Save

Addiction treatment declines among youths despite increase in ODs

Addiction treatment declines among youths despite increase in ODs

Buprenorphine dispensing among youths decreased significantly from 2015 to 2020 despite a rise in opioid-related overdoses, according to a study published in Pediatrics.

News
January 18, 2023
2 min read
Save

Buprenorphine-naloxone combo appears safe for treating opioid use disorder in pregnancy

Buprenorphine-naloxone combo appears safe for treating opioid use disorder in pregnancy

Women receiving buprenorphine-naloxone therapy for the treatment of opioid use disorder during pregnancy had similar outcomes vs. buprenorphine therapy alone in terms of maternal and neonatal health, data show.

News
December 13, 2022
1 min read
Save

New buprenorphine prescriptions far below expected levels during first year of pandemic

New buprenorphine prescriptions far below expected levels during first year of pandemic

Despite a constant number of active buprenorphine prescriptions, the number of new prescriptions during the first year of the COVID-19 pandemic was significantly below expected levels, according to a press release from Rand Corp.

View more